Tolvaptan: a selective vasopressin type 2 receptor antagonist in congestive heart failure.
about
V2 receptor antagonism with tolvaptan in heart failure.Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.Hyponatremia: an update on current pharmacotherapy.VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial.
P2860
Tolvaptan: a selective vasopressin type 2 receptor antagonist in congestive heart failure.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tolvaptan: a selective vasopre ...... t in congestive heart failure.
@ast
Tolvaptan: a selective vasopre ...... t in congestive heart failure.
@en
type
label
Tolvaptan: a selective vasopre ...... t in congestive heart failure.
@ast
Tolvaptan: a selective vasopre ...... t in congestive heart failure.
@en
prefLabel
Tolvaptan: a selective vasopre ...... t in congestive heart failure.
@ast
Tolvaptan: a selective vasopre ...... t in congestive heart failure.
@en
P2093
P2860
P1476
Tolvaptan: a selective vasopre ...... t in congestive heart failure.
@en
P2093
Alejandro Barbagelata
Barry F Uretsky
Cesare Orlandi
Umamahesh C Rangasetty
P2860
P304
P356
10.1517/13543784.15.5.533
P407
P577
2006-05-01T00:00:00Z